US FDA Approves First 'Viagra for Women'

The United States Food and Drug Administration (FDA) has approved a drug for the first time that increases sexual desire in women, effectively functioning like 'Viagra' for them. This is the first time a drug similar to Viagra, but for women, has been allowed for production and market release. The common name of this drug is 'Addyi', and it will only be available in specialized pharmacies and authorized centers. The reason for the limited availability of this drug is the potential risks it may pose to women who consume it. These potential risks have also led to various controversies regarding the approval and sale of 'Addyi', as warnings have been issued about its use by women with low blood pressure or its consumption alongside alcohol. Reuters reports that the FDA had previously rejected the drug 'Flibanserin' (Addyi), developed by a private pharmaceutical company, twice in 2010 and 2013. According to AFP, Janet Woodcock, the director of this regulatory agency, stated that this final approval is 'a help to women who have low sexual desire through a validated method.' This drug, dubbed 'the female Viagra', must be taken daily. Unlike Viagra, which affects blood flow to the sexual organs, 'Flibanserin' affects the brain. This drug is classified alongside antidepressants, such as 'Prozac'.